Brief: BioArctic Q1 Operating Profit SEK 1,075.3 Million
21/05/2025 07:01
May 21 (Reuters) - BioArctic Q1 revenue SEK 1,289.6 million. Q1 adjusted EPS SEK 11.55 Q1 adjusted free cash flow SEK 11.8 million Q1 net income SEK 1,021.5 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln